Failures of post-exposure rabies prophylaxis

Vaccine

Volumn 25, Issue 44, 2007, Pages 7605-7609

  Wilde, Henry ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Efficacy of post exposure prophylaxis; Failures of post exposure prophylaxis; Rabies post exposure prophylaxis

Indexed keywords

EQUINE RABIES IMMUNOGLOBULIN; FAVIRAB; PURIFIED VEROCELL RABIES VACCINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG;

ADULT; AFRICA; AGED; ARM; ARTICLE; AUTOPSY; CAUSE OF DEATH; CHEEK; CHILD; CLINICAL ARTICLE; DOG; DOG BITE; EARLY INTERVENTION; FACE; FEMALE; HUMAN; INFECTION PREVENTION; INTUBATION; MALE; MYANMAR; NOSE; PHILIPPINES; PRIORITY JOURNAL; RABIES; SOUTH AFRICA; THAILAND; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; WOUND CARE;

AGED; ANIMALS; BITES AND STINGS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; RABIES; RABIES VACCINES; WORLD HEALTH ORGANIZATION;

EID: 35048833272     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.054     Document Type: Article

References (23)

1. Wilde H., Sirikawin S., Subcharoen A., Kingnate D., Tantawichien T., Harischandra P.A., et al. Failure of post-exposure treatment of rabies in children. Clin Infect Dis 22 (1996) 228-232
2. Hemachudha T., Mitrabhakdi E., Wilde H., Vajabhuti A., Siripataravanit S., Kingnate D., et al. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis 28 (1999) 143-144
3. WHO Expert Consultation on Rabies. Technical Report 931. WHO, Geneva 2005.
4. World Health Organization. Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. EMC.ZOO 96.6. Geneva: WHO; 1996.
5. Wilde H. Rabies. In: Jong E.C., and Zuckerman J.N. (Eds). Traveler's vaccines (2004), BC Decker Inc., Hamilton, Ontario 200-218
6. Shill M., Baynes R.D., and Miller S.D. Fatal rabies encephalitis despite appropriate post-exposure prophylaxis: a case report. New Engl J Med 316 (1987) 1257-1258
7. Fishbein D.B., Sawer P., and Reid-Sanden F.L. Administration of human diploid cell rabies vaccine in the gluteal area. New Engl J Med 318 (1988) 124-125
8. Suntharasamai P., Warrell M.J., Warrell D.A., Viravan C., Laooresuwan S., Supanaranond W., et al. New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals. Lancet 2 July (8499) (1986) 129-131
9. Hasbahceci M., Kiyan M., Eyol E., Ewalt L.C., and Lodmall D.L. Human diploid-cell rabies vaccine: efficacy of four doses. Lancet 347 April (9006) (1996) 976-977
10. Benjavongkulchai M., Kositprapa C., Limsuwun K., Kawplod P., Thipkong P., Chomchey P., et al. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan. Vaccine 15 December (17-18) (1997) 1816-1819
11. Jaiiaroensup W., Lang J., Thipkong P., Wimalaratne O., Samranwataya P., Saikasen A., et al. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial). Vaccine 16 October (16) (1998) 1559-1562
12. Madhusudana S.N., and Tripathi K.K. Postexposure studies with human diploid cell rabies vaccine and purified chick embryo cell vaccine, comparative serological response in man. Zentralbl Bakteriol 271 (1989) 345-350
13. Khawplod P., Glueck R., Wilde H., Tantawichien T., Chamchay P., Thipkong P., et al. Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal post-exposure regimen. Clin Infect Dis 20 March (3) (1995) 646-651
14. Madhusudana S.N., Anand N.P., and Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis 6 September (3) (2002) 210-214
15. Sehgal S., Bhattacharya D., and Bhardwaj M. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. J Commun Dis 27 March (1) (1995) 36-43
16. Khawplod P., Wilde H., Tepsumethanon S., Limsanno S., Tantawichien T., Chomchey P., et al. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine (an effort to obtain early immune response without using immunoglobulin). Clin Infect Dis 35 (2002) 1562-1565
17. Hanlon C.A., Niezgoda M., Morrill P.A., and Rupprecht C.E. The incurable wound revisited: progress in human rabies prevention?. Vaccine 19 March (17-19) (2001) 2273-2279
18. Dean D.J., Baer G.M., and Thompson W.R. Studies on the local treatment of rabies infected wounds. Bull WHO 28 (1963) 477-486
19. Kaplan M.M., Cohen D., Koprowski H., Dean D., and Ferrigan L. Studies on the local treatment of wounds for the prevention of rabies. Bull WHO 26 (1962) 765-775
20. Suwansrinon K., Wilde H., Benjavongkulchai M., Lertjarutom S., Boonchang S., Suttisri R., et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long listing immunity. Vaccine 24 (2006) 3878-3880
21. Lang J., Hoa D.Q., Gioi N.V., Vien N.C., Nguyen C.V., Rouyrre N., et al. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an expanded programme on immunization session in Viet Nam: results of a comparative randomized trial. Trans R Soc Trop Med Hyg 93 (1999) 208-213
22. Sriaroon C., Daviratanasilpa S., Samsomranjai P., Kawplod P., Hemachudha T., Khamoltham T., et al. Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immunoglobulin. Vaccine 21 (2003) 3525-3526
23. John B.M., and Patnaik S.K. Fatal rabies despite appropriate prophylaxis. Indian Pediatr 42 (2005) 839-840 and personal communication with authors